Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
02:21pm, Tuesday, 18'th Oct 2022 Benzinga
Upgrades
According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
Where Stryker Stands With Analysts
01:24pm, Wednesday, 12'th Oct 2022 Benzinga
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
4
3
0
0
Last 30D
1
Income Plus Low Volatility Makes This Fund A Safe Haven
07:00am, Wednesday, 12'th Oct 2022
Are you looking for a relatively safe mutual fund haven amid current market carnage? Check out Madison Covered Call & Equity Income Fund (MENYX).
2 Healthcare Stocks That Could Help Make You a Fortune
03:00pm, Saturday, 08'th Oct 2022 The Motley Fool
If given enough time, these two stocks can do the heavy lifting in building wealth for you.
2 Healthcare Stocks That Could Help Make You a Fortune
11:00am, Saturday, 08'th Oct 2022
If given enough time, these two stocks can do the heavy lifting in building wealth for you.
Stryker - A Leading MedTech Company Worth A Second Look
04:13am, Saturday, 08'th Oct 2022
I've been taking long looks at dividend-paying solid companies with relatively low yield, but very high safeties. Stryker is my latest in a long line of this. Stryker is a multinational MedTech busine
Verano Holdings Corp. (VRNOF) Soars 31.3%: Is Further Upside Left in the Stock?
02:05pm, Friday, 07'th Oct 2022 Zacks Investment Research
Verano Holdings Corp. (VRNOF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be m
Stryker to host conference call on October 31, 2022
08:05pm, Thursday, 29'th Sep 2022 GlobeNewswire Inc.
Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Compan
Stryker to host conference call on October 31, 2022
04:05pm, Thursday, 29'th Sep 2022
Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company'
Stryker (SYK) Launches Q Guidance System for Spine Applications
03:12pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during guided spine surgery following its launch.
Stryker (SYK) Launches Q Guidance System for Spine Applications
12:47pm, Wednesday, 28'th Sep 2022
Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during guided spine surgery following its launch.
Dividend Champion, Contender, And Challenger Highlights: Week Of September 25
04:55am, Sunday, 25'th Sep 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Click here to see companies with upcoming ex-dividend dates and pay dates.
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod
03:41pm, Friday, 23'rd Sep 2022 Zacks Investment Research
Stryker's (SYK) OptaBlate bone tumor ablation system is set to offer a reliable solution for people living with painful metastatic tumors.
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod
12:47pm, Friday, 23'rd Sep 2022
Stryker's (SYK) OptaBlate bone tumor ablation system is set to offer a reliable solution for people living with painful metastatic tumors.
